Centiva Capital’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,867	Closed	-$432K	–	1644
2025 Q1	$432K	Sell	2,867 -8,644	-75%	-$1.45M	0.02%	894
2024 Q4	$2.12M	Buy	11,511 +4,246	+58%	+$818K	0.08%	306
2024 Q3	$1.43M	Buy	+7,265	New	+$1.51M	0.06%	634
2023 Q4	–	Sell	-5,768	Closed	-$1.13M	–	1872
2023 Q3	$1.13M	Buy	5,768 +3,964	+220%	+$814K	0.06%	575
2023 Q2	$379K	Buy	+1,804	New	+$359K	0.02%	981
2022 Q3	–	Sell	-1,909	Closed	-$409K	–	1556
2022 Q2	$409K	Buy	+1,909	New	+$466K	0.02%	1011
2021 Q4	–	Sell	-756	Closed	-$312K	–	1274
2021 Q3	$312K	Buy	756 +5	+0.7%	+$2.08K	0.02%	771
2021 Q2	$277K	Buy	+751	New	+$251K	0.02%	1077
2021 Q1	–	Sell	-968	Closed	-$242K	–	1194
2020 Q4	$242K	Buy	+968	New	+$231K	0.03%	718
2020 Q2	–	Sell	-6,230	Closed	-$786K	–	694
2020 Q1	$786K	Buy	6,230 +4,748	+320%	+$712K	0.12%	254
2019 Q4	$226K	Buy	+1,482	New	+$205K	0.04%	638